Patents Assigned to INSTITUT NATIONALE DE LE SANTE ET DE LA RECHERCHE MEDICALE
  • CD24CD38transitional B cells and CD9 as new biomarker of long-term human lung allograft survival
    Patent number: 11761960
    Abstract: The present invention relates to an in vitro method for determining the risk of occurrence of chronic lung graft dysfunction in a human subject comprising: a) measuring the level of CD9+ B cells in a blood sample of the subject, b) comparing the level of CD9+ B cells measured at step a) with one or more reference values of the level of CD9+ B cells, and c) determining the risk of occurrence of chronic lung graft dysfunction in the said subject from the comparison performed at step b).
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: September 19, 2023
    Assignees: UNIVERSITE DE NANTES, INSTITUT NATIONALE DE LE SANTE ET DE LA RECHERCHE MEDICALE, CHU NANTES
    Inventors: Carole Brosseau, Maxim Durand, Antoine Magnan, Sophie Brouard